Neuronova AB
Records under this name other than patents Neuronova AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Neuronova AB
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,969,702 | Compounds and methods for increasing neurogenesis Formerly held Term ended Term ended Mar 15, 2024 · USPTO record | Term ended | Term ended Mar 15, 2024 | USPTO record |
| US 8,318,704 | Modulation of neural stem cells and neural progenitor cells Formerly held Lapsed on the fee record Ended Nov 27, 2020 · USPTO record | Lapsed on the fee record | Ended Nov 27, 2020 | USPTO record |
| US 7,320,872 | Ependymal neural stem cells and method for their isolation Formerly held Lapsed on the fee record Ended Jan 22, 2020 · USPTO record | Lapsed on the fee record | Ended Jan 22, 2020 | USPTO record |
| US 7,279,332 | Method of isolating ependymal neural stem cells Formerly held Term ended Term ended Aug 19, 2019 · USPTO record | Term ended | Term ended Aug 19, 2019 | USPTO record |
| US 7,981,863 | Treatment of Parkinson's disease with PDGF Formerly held Lapsed on the fee record Ended Jul 19, 2019 · USPTO record | Lapsed on the fee record | Ended Jul 19, 2019 | USPTO record |
| US 7,811,822 | Modulation of neural stem cells and neural progenitor cells Formerly held Lapsed on the fee record Ended Oct 12, 2018 · USPTO record | Lapsed on the fee record | Ended Oct 12, 2018 | USPTO record |
| US 6,541,247 | Method of isolating ependymal neural stem cells Formerly held Term ended Term ended Jun 25, 2018 · USPTO record | Term ended | Term ended Jun 25, 2018 | USPTO record |